214 related articles for article (PubMed ID: 38510818)
1. Refractory Burkitt Lymphoma: Diagnosis and Interventional Strategies.
Malfona F; Testi AM; Chiaretti S; Moleti ML
Blood Lymphat Cancer; 2024; 14():1-15. PubMed ID: 38510818
[TBL] [Abstract][Full Text] [Related]
2. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
3. Targeted therapy in Burkitt lymphoma: Small molecule inhibitors under investigation.
Atallah-Yunes SA; Habermann TM; Khurana A
Br J Haematol; 2024 Jun; 204(6):2165-2172. PubMed ID: 38577716
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome of relapsed or refractory burkitt lymphoma and mature B-cell lymphoblastic leukemia in children and adolescents.
Kim H; Park ES; Lee SH; Koo HH; Kim HS; Lyu CJ; Jun SE; Lim YT; Baek HJ; Kook H; Lee JW; Kang HJ; Park KD; Shin HY; Ahn HS
Cancer Res Treat; 2014 Oct; 46(4):358-65. PubMed ID: 25043820
[TBL] [Abstract][Full Text] [Related]
5. Case Report: Unedited allogeneic chimeric antigen receptor T cell bridging to conditioning-free hematopoietic stem cell transplantation for a child with refractory Burkitt lymphoma.
Yang X; Luo C; Qian J; Huang X; Zhang J; Wang J; Luo C; Qin X; Li B; Chen J
Front Immunol; 2023; 14():1219872. PubMed ID: 37736096
[TBL] [Abstract][Full Text] [Related]
6. Chimeric Antigen Receptor-Modified T Cell Immunotherapy for Relapsed and Refractory Adult Burkitt Lymphoma.
Wu J; Cao Y; Zhang Q; Liu W; Zhou X; Ming X; Meng F; Zhang Y; Li C; Huang L; Wei J; Zheng M; Zhang S; Zhang T; Zhu X; Wang N; Wang J; Wang G; Zhou J; Liu B; Xiao Y
Front Immunol; 2022; 13():879983. PubMed ID: 35669773
[TBL] [Abstract][Full Text] [Related]
7. Extracorporeal photophoresis: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(6):1-82. PubMed ID: 23074497
[TBL] [Abstract][Full Text] [Related]
8. Treatment of relapsed/refractory paediatric aggressive B-cell non-Hodgkin lymphoma.
Moleti ML; Testi AM; Foà R
Br J Haematol; 2020 Jun; 189(5):826-843. PubMed ID: 32141616
[TBL] [Abstract][Full Text] [Related]
9. Relapsed/refractory Burkitt lymphoma and HIV infection.
Khan A; Brahim A; Ruiz M; Nagovski N
Int J STD AIDS; 2018 Jun; 29(7):695-703. PubMed ID: 29264956
[TBL] [Abstract][Full Text] [Related]
10. A case report of acquired immunodeficiency syndrome (AIDS)-related refractory Burkitt lymphoma got complete remission by multidisciplinary and multi-target combined therapy.
Zhang R; Sun J
Transl Cancer Res; 2022 Jun; 11(6):1806-1812. PubMed ID: 35836543
[TBL] [Abstract][Full Text] [Related]
11. Relapsed/refractory pediatric B-cell non-Hodgkin lymphoma treated with rituximab combination therapy: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group.
Osumi T; Mori T; Fujita N; Saito AM; Nakazawa A; Tsurusawa M; Kobayashi R
Pediatr Blood Cancer; 2016 Oct; 63(10):1794-9. PubMed ID: 27314926
[TBL] [Abstract][Full Text] [Related]
12. Primary refractory and relapsed adult acute lymphoblastic leukemia: characteristics, treatment results, and prognosis with salvage therapy.
Thomas DA; Kantarjian H; Smith TL; Koller C; Cortes J; O'Brien S; Giles FJ; Gajewski J; Pierce S; Keating MJ
Cancer; 1999 Oct; 86(7):1216-30. PubMed ID: 10506707
[TBL] [Abstract][Full Text] [Related]
13. Unusually swift response of relapsed Burkitt leukemia to R-DHAP.
Harrer DC; Denk A; Keil F; Menhart K; Mayer S; Wolff D; Edinger M; Herr W; Grube M
EJHaem; 2022 Aug; 3(3):1003-1008. PubMed ID: 36051076
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic Cell Transplantation and Adoptive Cell Therapy in Peripheral T Cell Lymphoma.
Rogers AM; Brammer JE
Curr Hematol Malig Rep; 2020 Aug; 15(4):316-332. PubMed ID: 32529515
[TBL] [Abstract][Full Text] [Related]
15. Sequential anti-CD19, 22, and 20 autologous chimeric antigen receptor T-cell (CAR-T) treatments of a child with relapsed refractory Burkitt lymphoma: a case report and literature review.
Du J; Zhang Y
J Cancer Res Clin Oncol; 2020 Jun; 146(6):1575-1582. PubMed ID: 32222815
[TBL] [Abstract][Full Text] [Related]
16. Novel Treatments of Adult T Cell Leukemia Lymphoma.
El Hajj H; Tsukasaki K; Cheminant M; Bazarbachi A; Watanabe T; Hermine O
Front Microbiol; 2020; 11():1062. PubMed ID: 32547515
[TBL] [Abstract][Full Text] [Related]
17. Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure.
Ayers EC; Li S; Medeiros LJ; Bond DA; Maddocks KJ; Torka P; Mier Hicks A; Curry M; Wagner-Johnston ND; Karmali R; Behdad A; Fakhri B; Kahl BS; Churnetski MC; Cohen JB; Reddy NM; Modi D; Ramchandren R; Howlett C; Leslie LA; Cytryn S; Diefenbach CS; Faramand R; Chavez JC; Olszewski AJ; Liu Y; Barta SK; Mukhija D; Hill BT; Ma H; Amengual JE; Nathan S; Assouline SE; Orellana-Noia VM; Portell CA; Chandar A; David KA; Giri A; Hess BT; Landsburg DJ
Cancer; 2020 Jan; 126(2):293-303. PubMed ID: 31568564
[TBL] [Abstract][Full Text] [Related]
18. EFFICACY OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN ADULT BURKITT/BURKITT-LIKE LYMPHOMA: A SYSTEMATIC REVIEW.
Joshi U; Subedi R; Nepal G; Gyawali S; Agrawal V; Poudyal BS; Bhatt VR; D'Angelo CR
Exp Oncol; 2022 Nov; 44(3):190-197. PubMed ID: 36325697
[TBL] [Abstract][Full Text] [Related]
19. Outcome of relapse in children and adolescents with B-cell non-Hodgkin lymphoma and mature acute leukemia: A report from the French LMB study.
Rigaud C; Auperin A; Jourdain A; Haouy S; Couec ML; Aladjidi N; Gandemer V; Lambliotte A; Plat G; Landman-Parker J; Michon J; Leblanc T; Patte C; Minard-Colin V
Pediatr Blood Cancer; 2019 Sep; 66(9):e27873. PubMed ID: 31207026
[TBL] [Abstract][Full Text] [Related]
20. Early relapse of Burkitt lymphoma heralded by a bone marrow necrosis and numb chin syndrome successfully treated with allogeneic stem cell transplantation.
Cerny J; Devitt K; Yu H; Ramanathan M; Woda B; Nath R
Leuk Res Rep; 2014; 3(2):51-3. PubMed ID: 25068102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
